摘要
人类在干细胞应用领域取得的成功仅仅是个开头。要使干细胞真正投入到临床治疗中，还有大量不可控的技术和伦理因素需要克服。
Stem Cell Fund lab in New York City,U.S.,recently announced that they had successfully used clone technology in cultivation of stem cell.Although the stem cell from this test cannot put into use,it is viewed as the closest thing to the normal human embryonic stem cell which is cultivated in lab.Due to the ethical barrier and unknown technical risk,it is very hard for embryonic stem cell application research to move forward.Therefore,the 'clone' cultivation method brings new hope to embryonic stem cell research.
出处
《中国医院院长》
2011年第21期36-37,10,共2页
China Hospital CEO
